Back to Search Start Over

In vivo labeling of the dopamine D2 receptor with N-11C-methyl-benperidol.

Authors :
Suehiro M
Dannals RF
Scheffel U
Stathis M
Wilson AA
Ravert HT
Villemagne VL
Sanchez-Roa PM
Wagner HN Jr
Source :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 1990 Dec; Vol. 31 (12), pp. 2015-21.
Publication Year :
1990

Abstract

A new dopamine D2 receptor radiotracer, N-11C-methyl-benperidol (11C-NMB), was prepared and its in vivo biologic behavior in mice and a baboon was studied. Carbon-11-NMB was determined to bind to specific sites characterized as dopamine D2 receptors. The binding was saturable, reversible, and stereospecific. Kinetic studies in the dopamine D2 receptor-rich striatum showed that 11C-NMB was retained five times longer than in receptor-devoid regions, resulting in a high maximum striatal-to-cerebellar ratio of 11:1 at 60 min after injection. From frontal cortex and cortex, on the other hand, the tracer washed out as rapidly as it did from cerebellum, resulting in tissue-to-cerebellar ratios close to one in these regions at any time after injection. Blocking studies confirmed the specificity and selectivity of the 11C-NMB binding to the dopamine D2 receptor. A PET study with 11C-NMB of the baboon brain revealed highly selective labeling of dopamine D2 receptor sites which was blocked by preinjection of raclopride.

Details

Language :
English
ISSN :
0161-5505
Volume :
31
Issue :
12
Database :
MEDLINE
Journal :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Type :
Academic Journal
Accession number :
2148346